Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jul-22 4:40 PM View:  | Keros Therapeutics, Inc. (KROS) | 15-Jul-22 | Option Exercise | 46,034 | $0.30 | $13,810.20 | 48% 95.1K to 141.13K | |
| 19-Jul-22 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 15-Jul-22 | Planned Option Sale | 46,034 | $30.00 | $1,381,020.00 | (33%) 141.13K to 95.1K | |
| 15-Jul-22 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Jul-22 | Option Exercise | 1,916 | $0.30 | $574.80 | 2% 95.1K to 97.02K | |
| 15-Jul-22 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Jul-22 | Planned Option Sale | 1,916 | $30.00 | $57,480.00 | (2%) 97.02K to 95.1K | |
| 14-Jun-22 6:57 PM View: | Keros Therapeutics, Inc. (KROS) | 14-Jun-22 | Option Exercise | 9,400 | $0.30 | $2,820.00 | 11% 85.7K to 95.1K | |
| 13-May-22 4:37 PM View: | Keros Therapeutics, Inc. (KROS) | 11-May-22 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 6% 85.7K to 91.0K | |
| 13-May-22 4:37 PM View: | Keros Therapeutics, Inc. (KROS) | 11-May-22 | Planned Option Sale | 5,300 | $41.90 | $222,050.00 | (6%) 91.0K to 85.7K | |
| 13-Apr-22 4:36 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Apr-22 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 6% 85.7K to 91.0K | |
| 13-Apr-22 4:36 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Apr-22 | Planned Option Sale | 5,300 | $62.77 | $332,705.00 | (6%) 91.0K to 85.7K | |
| 06-Apr-22 4:49 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Apr-22 | Option Exercise | 7,950 | $0.30 | $2,385.00 | 9% 85.7K to 93.65K | |
| 06-Apr-22 4:49 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Apr-22 | Planned Option Sale | 7,950 | $60.00 | $477,000.00 | (8%) 93.65K to 85.7K | |
| 15-Mar-22 4:37 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Mar-22 | Option Exercise | 2,650 | $0.30 | $795.00 | 3% 85.7K to 88.35K | |
| 15-Mar-22 4:37 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Mar-22 | Planned Option Sale | 2,650 | $53.38 | $141,449.00 | (3%) 88.35K to 85.7K | |
| 15-Feb-22 4:26 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Feb-22 | Option Exercise | 2,650 | $0.30 | $795.00 | 3% 85.7K to 88.35K | |
| 15-Feb-22 4:26 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Feb-22 | Planned Option Sale | 2,650 | $52.06 | $137,965.00 | (3%) 88.35K to 85.7K | |
| 13-Jan-22 4:39 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Jan-22 | Option Exercise | 2,650 | $0.30 | $795.00 | 3% 85.7K to 88.35K | |
| 13-Jan-22 4:39 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Jan-22 | Planned Option Sale | 2,650 | $53.75 | $142,447.00 | (3%) 88.35K to 85.7K | |
| 07-Jan-22 4:35 PM View: | Keros Therapeutics, Inc. (KROS) | 05-Jan-22 | Option Exercise | 2,650 | $0.30 | $795.00 | 3% 85.7K to 88.35K | |
| 07-Jan-22 4:35 PM View: | Keros Therapeutics, Inc. (KROS) | 05-Jan-22 | Market Option Sale (Planned) | 2,650 | $60.00 | $159,000.00 | (3%) 88.35K to 85.7K | |
| 15-Dec-21 4:48 PM View: | Keros Therapeutics, Inc. (KROS) | 15-Dec-21 | Option Exercise | 735 | $0.30 | $220.50 | < 1% 85.7K to 86.44K | |
| 15-Dec-21 4:48 PM View: | Keros Therapeutics, Inc. (KROS) | 15-Dec-21 | Market Option Sale (Planned) | 735 | $50.00 | $36,750.00 | (< 1%) 86.44K to 85.7K | |
| 15-Dec-21 4:48 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Dec-21 | Option Exercise | 1,915 | $0.30 | $574.50 | 2% 85.7K to 87.61K | |
| 15-Dec-21 4:48 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Dec-21 | Market Option Sale (Planned) | 1,915 | $50.55 | $96,808.30 | (2%) 87.61K to 85.7K | |
| 12-Nov-21 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Nov-21 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 6% 85.7K to 91.0K | |
| 12-Nov-21 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Nov-21 | Market Option Sale (Planned) | 5,300 | $59.63 | $316,058.00 | (6%) 91.0K to 85.7K | |
| 12-Nov-21 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 10-Nov-21 | Option Exercise | 15,900 | $0.30 | $4,770.00 | 19% 85.7K to 101.6K | |
| 12-Nov-21 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 10-Nov-21 | Market Option Sale (Planned) | 15,900 | $60.00 | $954,000.00 | (16%) 101.6K to 85.7K | |
| 05-Nov-21 5:06 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Nov-21 | Option Exercise | 10,600 | $0.30 | $3,180.00 | 12% 85.7K to 96.3K | |
| 05-Nov-21 5:06 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Nov-21 | Market Option Sale (Planned) | 10,600 | $50.00 | $530,000.00 | (11%) 96.3K to 85.7K | |
| 18-Aug-21 5:21 PM View: | Keros Therapeutics, Inc. (KROS) | 17-Aug-21 | Option Exercise | 1,293 | $0.30 | $387.90 | 2% 84.41K to 85.7K | |
| 25-Jun-21 6:29 PM View: | Keros Therapeutics, Inc. (KROS) | 24-Jun-21 | Option Exercise | 6,500 | $0.30 | $1,950.00 | 8% 77.91K to 84.41K | |
| 15-Jun-21 5:02 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Jun-21 | Option Exercise | 2,650 | $0.30 | $795.00 | 3% 77.91K to 80.56K | |
| 15-Jun-21 5:02 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Jun-21 | Market Option Sale (Planned) | 2,650 | $50.98 | $135,087.00 | (3%) 80.56K to 77.91K | |
| 13-May-21 4:36 PM View: | Keros Therapeutics, Inc. (KROS) | 13-May-21 | Option Exercise | 6,720 | $0.12 | $834.20 | 9% 71.19K to 77.91K | |
| 13-May-21 4:36 PM View: | Keros Therapeutics, Inc. (KROS) | 11-May-21 | Option Exercise | 2,650 | $0.30 | $795.00 | 4% 71.19K to 73.84K | |
| 13-May-21 4:36 PM View: | Keros Therapeutics, Inc. (KROS) | 11-May-21 | Market Option Sale (Planned) | 2,650 | $50.00 | $132,500.00 | (4%) 73.84K to 71.19K | |
| 14-Apr-21 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 12-Apr-21 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 7% 71.19K to 76.49K | |
| 14-Apr-21 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 12-Apr-21 | Market Option Sale (Planned) | 5,300 | $60.01 | $318,026.00 | (7%) 76.49K to 71.19K | |
| 02-Apr-21 4:32 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Apr-21 | Option Exercise | 9,996 | $0.11 | $1,099.56 | 16% 61.19K to 71.19K | |
| 15-Mar-21 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Mar-21 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 9% 61.19K to 66.49K | |
| 15-Mar-21 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Mar-21 | Market Option Sale (Planned) | 5,300 | $64.48 | $341,750.00 | (8%) 66.49K to 61.19K | |
| 01-Mar-21 4:54 PM View: | Keros Therapeutics, Inc. (KROS) | 26-Feb-21 | Option Exercise | 33,200 | $0.11 | $3,652.00 | 119% 27.99K to 61.19K | |
| 16-Feb-21 5:47 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Feb-21 | Option Exercise | 5,300 | $0.30 | $1,590.00 | 19% 27.99K to 33.29K | |
| 16-Feb-21 5:47 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Feb-21 | Market Option Sale (Planned) | 5,300 | $64.91 | $344,017.00 | (16%) 33.29K to 27.99K |